Hypoxia may be a determinative factor in COVID-19 progression

The disease which develops following SARS-CoV-2 virus infection, known as COVID-19, in most affected countries displays mortality from 1.5% to 9.8%. When leukocytosis due to granulocytosis, thrombocytopenia, and increased level of D-dimers are detected early during the disease course, they are accur...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Res Pharmacol Drug Discov
Main Authors: Grieb, Pawel, Swiatkiewicz, Maciej, Prus, Katarzyna, Rejdak, Konrad
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2021
Fag:
COVID-19 therapy
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106824/
https://ncbi.nlm.nih.gov/pubmed/34870146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.crphar.2021.100030
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker